Lieber Jonathan I
Insider CIK 1350090 · AGTC Chief Financial Officer · HSGX Chief Financial Officer · DCOY Director · RLYB See Remarks · RGEN CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RLYB Rallybio Corp | M Exercise deriv | 2026-10-29 | 2026-11-02 | 13,589 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | M Exercise deriv | 2026-10-29 | 2026-11-02 | 7,875 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | M Exercise | 2026-10-29 | 2026-11-02 | 13,589 | $6.08 | $82.6K | 37,015 | SEC↗ |
| RLYB Rallybio Corp | M Exercise | 2026-10-29 | 2026-11-02 | 7,875 | $14.88 | $117.2K | 23,426 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2026-10-27 | 2026-10-28 | 599 | $16.04 | $9.6K | 15,551 | SEC↗ |
| RLYB Rallybio Corp | A Award | 2026-10-26 | 2026-10-28 | 2,500 | — | $0 | 16,150 | SEC↗ |
| RLYB Rallybio Corp | M Exercise deriv | 2026-10-09 | 2026-10-13 | 3,910 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | M Exercise | 2026-10-09 | 2026-10-13 | 3,910 | $6.08 | $23.8K | 13,650 | SEC↗ |
| RLYB Rallybio Corp | M Exercise deriv | 2026-09-29 | 2026-10-01 | 5,000 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | M Exercise | 2026-09-29 | 2026-10-01 | 5,000 | $6.08 | $30.4K | 9,740 | SEC↗ |
| DCOY Decoy Therapeutics Inc. | A Award | 2026-08-31 | 2026-09-02 | 2,000 | — | $0 | 2,002 | SEC↗ |
| DCOY Decoy Therapeutics Inc. | A Award | 2026-08-31 | 2026-09-02 | 2,000 | — | $0 | 2,002 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2026-02-23 | 2026-02-23 | 789 | $5.06 | $4.0K | 4,115 | SEC↗ |
| RLYB Rallybio Corp | A Award | 2026-02-18 | 2026-02-23 | 2,500 | — | $0 | 4,904 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2025-02-14 | 2025-02-19 | 180,000 | — | $0 | 180,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2024-02-20 | 2024-02-22 | 20,500 | — | $0 | 20,500 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2024-02-15 | 2024-02-16 | 120,000 | — | $0 | 120,000 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2023-03-14 | 2023-03-16 | 5,000 | $5.21 | $26.1K | 5,000 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2023-02-01 | 2023-02-01 | 240,000 | — | $0 | 240,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2023-01-03 | 2023-01-05 | 1,440 | — | $0 | 2,940 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 202,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 154,700 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2022-08-21 | 2022-08-24 | 154,700 | — | $0 | 154,700 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2022-06-07 | 2022-06-08 | 37,500 | $0.19 | $7.1K | 37,500 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2022-01-20 | 2022-01-21 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2021-09-20 | 2021-09-21 | 202,000 | — | $0 | 202,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2020-12-02 | 2020-12-04 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2020-07-14 | 2020-07-16 | 3,000 | — | $0 | 3,000 | SEC↗ |
| HSGX HISTOGENICS CORP | D To issuer deriv | 2018-10-01 | 2018-10-03 | 110,000 | — | $0 | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2018-10-01 | 2018-10-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HSGX HISTOGENICS CORP | D To issuer deriv | 2018-10-01 | 2018-10-03 | 50,000 | — | $0 | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2018-10-01 | 2018-10-03 | 28,000 | — | $0 | 28,000 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2018-10-01 | 2018-10-03 | 130,000 | — | $0 | 130,000 | SEC↗ |
| HSGX HISTOGENICS CORP | D To issuer deriv | 2018-10-01 | 2018-10-03 | 30,000 | — | $0 | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | D To issuer deriv | 2018-10-01 | 2018-10-03 | 130,000 | — | $0 | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2018-10-01 | 2018-10-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| HSGX HISTOGENICS CORP | D To issuer deriv | 2018-10-01 | 2018-10-03 | 28,000 | — | $0 | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2018-02-16 | 2018-02-21 | 130,000 | — | $0 | 130,000 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2017-02-14 | 2017-02-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HSGX HISTOGENICS CORP | P Buy | 2016-12-02 | 2016-12-02 | 5,000 | $1.95 | $9.8K | 5,000 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2016-02-26 | 2016-03-01 | 28,000 | — | $0 | 28,000 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2015-07-02 | 2015-07-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2015-07-02 | 2015-07-06 | 110,000 | — | $0 | 110,000 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2013-02-28 | 2013-03-12 | 40,000 | — | $0 | 150,000 | SEC↗ |